Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Gilead Sciences (GILD) or Vertex Pharmaceuticals (VRTX). But which of ... Value category of ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Zacks Rank system, stretching from #1 (Strong Buy ... We can also see that VRTX currently has a PEG ratio of 588.17. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The company’s shares closed yesterday at $472.80.

The Value category of the Style Scores system identifies undervalued companies ... BMY currently has a forward P/E ratio of 70.56, while VRTX has a forward P/E of 7,711.13. We also note that ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched ... The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and ...